CATALAYER NEWS

Evogene targets acute graft-versus-host disease in drug program

Source: Investing.com · 2026-10-28

Full article text is available in the Catalayer news terminal.

MORE FROM INVESTING.COM
Extreme Networks Q1 FY27 slides: revenue beats, margins expand
2026-10-28
SiteOne Q3 2026 slides: margins expand despite soft demand, shares fall
2026-10-28
SolarEdge Technologies stock hits 52-week low at $28.18
2026-10-28
PHX Energy at Planet MicroCap Toronto: tech edge drives growth
2026-10-28
Earnings call transcript: Delivery Hero posts record Q3 2026 revenue beat
2026-10-28
RELATED ON CATALAYER
Mentioned Tickers
$TGT · Target
Related Topics
EV & Auto Industry NewsRetail & E-commerce News
RELATED MARKETS
Prediction Markets
Xi Jinping out before 2027?4%Will Gavin Newsom win the 2028 Democratic presidential nomination?17%Will Alexandria Ocasio-Cortez win the 2028 Democratic presidential nomination?16%
Open Catalayer terminal for live tracking →